We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire ROCKVILLE, Md., April 25, 2024 ROCKVILLE...
AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and ...
AstraZeneca PLC 25 April 2024 AstraZeneca 25 April 2024 Q1 2024 results Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery Revenue and EPS...
Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC. Shares in Angle were up 24% to ...
Deutsche Bank on Tuesday removed AstraZeneca from its 'sell' list, citing an improved dividend and improved forecasts ...
AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced ...
AstraZeneca PLC 11 April 2024 11 April 2024 1730 BST Results of Annual General Meeting held on 11 April 2024 AstraZeneca PLC announced the results of the voting at its Annual General...
AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performa ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1080 | 9.86661794263 | 10946 | 12096 | 10764 | 2604497 | 11196.6705809 | DE |
4 | 1270 | 11.8073633321 | 10756 | 12096 | 10418 | 2014680 | 10926.8957565 | DE |
12 | 1478 | 14.0121350019 | 10548 | 12096 | 9461 | 2714742 | 10344.2189487 | DE |
26 | 1560 | 14.9054079878 | 10466 | 12096 | 9461 | 2379434 | 10357.2358298 | DE |
52 | -86 | -0.710039630119 | 12112 | 12348 | 9461 | 2135013 | 10671.9385176 | DE |
156 | 4484 | 59.4537258022 | 7542 | 12390 | 7392 | 2236876 | 9984.91965243 | DE |
260 | 6093 | 102.696780718 | 5933 | 12390 | 5626 | 2276781 | 8951.25731317 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions